These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2436999)

  • 1. Plasma requirement for expression of lupus-like anticoagulant.
    Clyne LP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):841-4. PubMed ID: 2436999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lupus anticoagulant and retinal vaso-occlusive disease.
    Fitzpatrick EP; Chesen N; Rahn EK
    Ann Ophthalmol; 1990 Apr; 22(4):148-52. PubMed ID: 2112354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assays for lupus anticoagulant: the sensitivity of different assays.
    Jain A; Dash S; Marwaha N; Deodhar SD; Sehgal S
    Med Lab Sci; 1991 Jan; 48(1):31-5. PubMed ID: 1905773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Presentation of 20 cases of lupus anticoagulant. Proposal for a methodology for its study].
    Mompel Sanjuán A; Abad Gosalbez A; García Pérez A; Marco Vera P
    Sangre (Barc); 1988 Aug; 33(4):306-9. PubMed ID: 3142061
    [No Abstract]   [Full Text] [Related]  

  • 5. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary thromboembolism in a patient with circulating lupus anticoagulant].
    Rodríguez Pascual L; Martín Escudero JC; Carretero Sastre JL; Blanco Cabero JM; Tortosa Cavero JI
    Sangre (Barc); 1987; 32(4):506-11. PubMed ID: 3116688
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological and clinical heterogeneity of lupus and lupus-like anticoagulant in fifty-seven patients.
    Horellou MH; Aurousseau MH; Boffa MC; Conrad J; Wiesel ML; Samama M
    J Med; 1987; 18(3-4):199-217. PubMed ID: 3480933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening method of lupus anticoagulants using coagulation technics: clinical application to patients with SLE and habitual abortion].
    Motoi S; Suehisa E; Nishimura K; Amino N; Miyai K; Mori M; Tanizawa O
    Rinsho Byori; 1988 Jan; 36(1):71-6. PubMed ID: 3130514
    [No Abstract]   [Full Text] [Related]  

  • 9. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
    Kelsey PR; Stevenson KJ; Poller L
    Thromb Haemost; 1984 Oct; 52(2):172-5. PubMed ID: 6441303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The laboratory heterogeneity of lupus anticoagulants.
    Triplett DA; Brandt JT; Maas RL
    Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinuclear antibody-negative systemic lupus erythematosus (SLE) and severe renal involvement: close correlation between disease activity and appearance of circulating anticoagulant.
    Raz E; Michaeli J; Rosenmann E; Rubinow A; Popovtzer MM
    Isr J Med Sci; 1988 Feb; 24(2):105-8. PubMed ID: 3128493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations of the lupus-like inhibitor by-passing activity of platelets.
    Howard MA; Firkin BG
    Thromb Haemost; 1983 Dec; 50(4):775-9. PubMed ID: 6420922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lupus-type anticoagulants and thromboses].
    Sultan Y
    Ann Med Interne (Paris); 1986; 137(6):475-6. PubMed ID: 3101565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circulating anticoagulants and pregnancy: a risky combination].
    Dantal J; Dantal F; Sagot P; Lopes P; Lerat MF
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(3):317-24. PubMed ID: 3135300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus].
    Font J; Cervera R; Casals FJ; Bové A; Guerrero A; López-Soto A; Ingelmo M; Urbano-Márquez A
    Med Clin (Barc); 1988 Mar; 90(12):490-3. PubMed ID: 3134583
    [No Abstract]   [Full Text] [Related]  

  • 17. Central retinal-artery occlusion in a patient with circulating lupus anticoagulant.
    Reisin LH; Reisin I; Darawshi A; Aviel E
    Ann Ophthalmol; 1989 Jul; 21(7):269-71. PubMed ID: 2505658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
    Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Selva O'Callaghan A; Alijotas Reig J; Bosch Gil J
    Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program.
    Brandt JT; Triplett DA; Rock WA; Bovill EG; Arkin CF
    Arch Pathol Lab Med; 1991 Feb; 115(2):109-14. PubMed ID: 1899555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and quantitative evaluation of lupus circulating anticoagulant activity.
    Rosner E; Pauzner R; Lusky A; Modan M; Many A
    Thromb Haemost; 1987 Apr; 57(2):144-7. PubMed ID: 3110995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.